The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution.

Miligy, Islam M; Toss, Michael S; Gorringe, Kylie L; Lee, Andrew H S; Ellis, Ian O; Green, Andrew R; Rakha, Emad A

Miligy, Islam M; Toss, Michael S; Gorringe, Kylie L; Lee, Andrew H S; Ellis, Ian O; Green, Andrew R; Rakha, Emad A.

Affiliation

Miligy IM; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham, Nottingham, UK.
Toss MS; Histopathology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt.
Gorringe KL; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham, Nottingham, UK.
Lee AHS; Histopathology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Ellis IO; Cancer Genomics Program, Peter MacCallum Cancer Centre, Melbourne, University of Melbourne, Parkville, Australia.
Green AR; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
Rakha EA; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham, Nottingham, UK.

Br J Cancer ; 120(11): 1075-1082, 2019 05.

Article in En | MEDLINE | ID: mdl-31065110

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma, Intraductal, Noninfiltrating / Receptor, ErbB-2 Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Br J Cancer Year: 2019 Document type: Article Affiliation country: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google